Literature DB >> 24606701

Viral kinetics of primary dengue virus infection in non-human primates: a systematic review and individual pooled analysis.

Benjamin M Althouse1, Anna P Durbin2, Kathryn A Hanley3, Scott B Halstead4, Scott C Weaver5, Derek A T Cummings2.   

Abstract

Viremia kinetics directly influence the clinical course and transmission dynamics of DENV, but many aspects of viral dynamics remain unknown. Non-human primates (NHP) have been used as a model system for DENV infection for decades. Here, we identify papers with experimentally-infected NHP and estimate the time to- and duration of viremia as well as estimate associations between these and serotype, inoculating dose, viremia assay, and species of NHP. We estimate the time to viremia in rhesus macaques to range from 2.63 to 3.32 days for DENV-2 and -1 and the duration to range from 3.13 to 5.13 days for DENV-4 and -2. We find no differences between non-human primates for time to viremia or duration, and a significant negative relationship between inoculating dose and duration of viremia. These results aid in understanding the transmission dynamics of sylvatic DENV non-human primates, an issue of growing importance as dengue vaccines become available.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dengue virus; Non-human primates; Sylvatic dengue; Viral kinetics; Within-host dynamics

Mesh：

Year:  2014        PMID： 24606701      PMCID： PMC4578724          DOI： 10.1016/j.virol.2014.01.015

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  78 in total

1.  Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys.

Authors:  Lewis Markoff; Xiaou Pang; Huo-shu Houng Hs; Barry Falgout; Raymond Olsen; Estella Jones; Stephanie Polo
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Characterization of antibody responses to combinations of a dengue virus type 2 DNA vaccine and two dengue virus type 2 protein vaccines in rhesus macaques.

Authors:  Monika Simmons; Kevin R Porter; Curtis G Hayes; David W Vaughn; Robert Putnak
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge.

Authors:  R Men; L Wyatt; I Tokimatsu; S Arakaki; G Shameem; R Elkins; R Chanock; B Moss; C J Lai
Journal:  Vaccine       Date:  2000-07-15       Impact factor: 3.641

4.  A live, attenuated recombinant West Nile virus vaccine.

Authors:  Thomas P Monath; Jian Liu; Niranjan Kanesa-Thasan; Gwendolyn A Myers; Richard Nichols; Alison Deary; Karen McCarthy; Casey Johnson; Thomas Ermak; Sunheang Shin; Juan Arroyo; Farshad Guirakhoo; Jeffrey S Kennedy; Francis A Ennis; Sharone Green; Philip Bedford
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

5.  Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999.

Authors:  Ananda Nisalak; Timothy P Endy; Suchitra Nimmannitya; Siripen Kalayanarooj; Usa Thisayakorn; Robert M Scott; Donald S Burke; Charles H Hoke; Bruce L Innis; David W Vaughn
Journal:  Am J Trop Med Hyg       Date:  2003-02       Impact factor: 2.345

6.  Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006.

Authors:  Jessica R Fried; Robert V Gibbons; Siripen Kalayanarooj; Stephen J Thomas; Anon Srikiatkhachorn; In-Kyu Yoon; Richard G Jarman; Sharone Green; Alan L Rothman; Derek A T Cummings
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

7.  Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.

Authors:  Robert Putnak; James Fuller; Lorna VanderZanden; Bruce L Innis; David W Vaughn
Journal:  Am J Trop Med Hyg       Date:  2003-04       Impact factor: 2.345

8.  Serotype-specific differences in clinical manifestations of dengue.

Authors:  Angel Balmaseda; Samantha N Hammond; Leonel Pérez; Yolanda Tellez; Saira Indira Saborío; Juan Carlos Mercado; Ricardo Cuadra; Julio Rocha; Maria Angeles Pérez; Sheyla Silva; Crisanta Rocha; Eva Harris
Journal:  Am J Trop Med Hyg       Date:  2006-03       Impact factor: 2.345

9.  Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam.

Authors:  Annette Fox; Nguyen Minh Hoa Le; Cameron P Simmons; Marcel Wolbers; Heiman F L Wertheim; Thi Khuong Pham; Thi Hai Ninh Tran; Thi Minh Lien Trinh; Thi Lien Nguyen; Vu Trung Nguyen; Duc Hien Nguyen; Jeremy Farrar; Peter Horby; Walter R Taylor; Van Kinh Nguyen
Journal:  PLoS Negl Trop Dis       Date:  2011-03-01

10.  Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Jeremy Farrar; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06
View more
  23 in total

Review 1.  The tortoise or the hare? Impacts of within-host dynamics on transmission success of arthropod-borne viruses.

Authors:  Benjamin M Althouse; Kathryn A Hanley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-08-19       Impact factor: 6.237

2.  How season and serotype determine dengue transmissibility.

Authors:  Neil M Ferguson; Derek A T Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

3.  Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.

Authors:  Georg F Bischof; Diogo M Magnani; Michael Ricciardi; Young C Shin; Aline Domingues; Varian K Bailey; Lucas Gonzalez-Nieto; Eva G Rakasz; David I Watkins; Ronald C Desrosiers
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

4.  Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.

Authors:  Kathryn A Hanley; Mathilde Guerbois; Tiffany F Kautz; Meredith Brown; Stephen S Whitehead; Scott C Weaver; Nikos Vasilakis; Preston A Marx
Journal:  Am J Trop Med Hyg       Date:  2014-08-04       Impact factor: 2.345

5.  Seroprevalence of Dengue, Zika, and Chikungunya Viruses in Wild Monkeys in Thailand.

Authors:  Daraka Tongthainan; Nanthanida Mongkol; Kultida Jiamsomboon; Sarocha Suthisawat; Pornchai Sanyathitiseree; Manakorn Sukmak; Worawidh Wajjwalku; Yong Poovorawan; Gittiyaporn Ieamsaard; Bencharong Sangkharak; Kanokwan Taruyanon; Wirasak Fungfuang; Phitsanu Tulayakul; Kobporn Boonnak
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

6.  A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.

Authors:  Gregg N Milligan; Vanessa V Sarathy; Ernesto Infante; Li Li; Gerald A Campbell; P Robert Beatty; Eva Harris; Alan D T Barrett; Nigel Bourne
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

Review 7.  Potential for Zika Virus to Establish a Sylvatic Transmission Cycle in the Americas.

Authors:  Benjamin M Althouse; Nikos Vasilakis; Amadou A Sall; Mawlouth Diallo; Scott C Weaver; Kathryn A Hanley
Journal:  PLoS Negl Trop Dis       Date:  2016-12-15

8.  Drivers of Inter-individual Variation in Dengue Viral Load Dynamics.

Authors:  Rotem Ben-Shachar; Scott Schmidler; Katia Koelle
Journal:  PLoS Comput Biol       Date:  2016-11-17       Impact factor: 4.475

Review 9.  Utility, limitations, and future of non-human primates for dengue research and vaccine development.

Authors:  Carlos A Sariol; Laura J White
Journal:  Front Immunol       Date:  2014-09-24       Impact factor: 7.561

10.  First evidence of dengue infection in domestic dogs living in different ecological settings in Thailand.

Authors:  Suporn Thongyuan; Pattamaporn Kittayapong
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.